• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Waldenstrom’s macroglobulinaemia - Articles and news items

NICE does not recommend Janssen’s Waldenstrom’s macroglobulinaemia candidate

Industry news / 17 October 2016 / Niamh Louise Marriott, Digital Content Producer

NICE has published draft guidance that does not recommend Janssen’s Imbruvica (ibrutinib) for treating some people with Waldenstrom’s macroglobulinaemia…


Webinar: SIFT-MS: A New Tool for Impurity Profiling in Pharmaceutical ProductsLEARN MORE
+ +